Constipation and bloating are among the most common digestive side effects of GLP-1 medications like Ozempic and Wegovy.
Relievance Fiber is a physician-developed fiber supplement designed to support digestive comfort during GLP-1 therapy
Physician-developed · 8-fiber blend · Sugar-free
GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) slow the rate at which food moves through the digestive tract.
This delayed gastric emptying is intentional — it helps reduce appetite — but it also means food sits longer in the gut, which commonly leads to constipation, bloating, nausea, gas, and general digestive discomfort.
These symptoms are among the most frequently reported reasons people reduce their GLP-1 dose or consider stopping treatment altogether.
Fantastic product! Helped reduce my bloating substantially after a few days of taking it. Love that it has no artificial ingredients or food dyes too.
This product is awesome, I will definitely be purchasing again! I love that I can mix it into my smoothies since it does not have any flavors.
This is the best supplement for digestive issues. I mix it in with my morning yogurt or smoothie and you can’t taste it at all. It is seriously the only thing I have found to help with regularity and digestive comfort.
Tasteless which is great! Mixes in great with my protein shakes
Really helps with bloating and abdominal discomfort. Great fiber product.
I’ve been taking a GLP-1 for 22 months and experiencing the bloating and constipation as a result of a slowed GI tract. Relievance is the first product I’ve tried that effectively relieves both bloating and constipation.
We have been searching for a premium fiber supplement that meets our highest expectations. Relievance is AWESOME. We love it and will certainly buy again.
Dietary fiber adds bulk to stool and helps stimulate normal bowel movement patterns — directly counteracting the slowed motility caused by GLP-1 medications.
Soluble fiber also nourishes the gut microbiome, supporting smoother movement through the digestive tract and reduces bloating and pressure.
People taking GLP-1 medications often eat less, which unintentionally reduces fiber intake at the moment when gut support is needed most. Supplementing with a targeted fiber 8-blend can help fill this gap.
Relievance is designed for long-term metabolic and digestive support.
Most fiber supplements rely on a single ingredient.
Relievance combines eight complementary fiber sources, each supporting digestive health in a different way — together forming a more complete approach to gut support during GLP-1 therapy.
Soluble Fiber
Nourishes the gut microbiome supporting smoother stool movement and reducing bloating.
Insoluble Fiber
Adds bulk to stool and supports regular bowel movements — especially helpful when GLP-1 slows motility.
Prebiotic Fiber
Feeds beneficial gut bacteria that influence digestion, microbiome diversity, and overall gut balance.
Fermentable Fiber
Supports gut bacteria metabolic activity and helps maintain microbiome diversity during the dietary changes that come with GLP-1 therapy.
A more diverse fiber intake supports a healthier gut environment — and may help reduce digestive side effects associated with GLP-1 medications.
Relievance Fiber is designed for consistent daily use alongside GLP-1 therapy to support digestive comfort over time.
Relievance Fiber may help people who are currently taking or starting GLP-1 medications and want:
Constipation Relief
Difficulty with regular bowel movements during Ozempic or Wegovy treatment
Bloating & Gas Relief
Abdominal pressure and discomfort associated with slowed digestion on GLP-1s
Gut Microbiome Health
Maintaining a diverse and balanced microbiome while on a GLP-1 regimen
Digestive Comfort
Overall digestive ease and regularity during GLP-1 therapy
The Relievance formula supports digestive wellness for both men and women on GLP-1 therapy.
Discover the physician-developed 8-fiber supplement designed to help relieve constipation, bloating, gas and digestive discomfort during GLP-1 therapy.